Medicxi Ventures Management (Jersey) Ltd - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on January 23, 2026, for the 2025 Q4 period, Medicxi Ventures Management (Jersey) Ltd held in its portfolio 5 assets valued at $834,980,337 (i.e. $834.98M).

The most valuable assets in the portfolio included: CENTESSA PHARMACEUTICALS PLC ($499.28M), PHATHOM PHARMACEUTICALS INC ($123.84M), and NEWAMSTERDAM PHARMA COMPANY ($100.66M).

The chart below shows the top 5 valuable assets, and the table below shows the top 5 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in Medicxi Ventures Management (Jersey) Ltd Portfolio

CENTESSA PHARMACEUTICALS PLC

PHATHOM PHARMACEUTICALS INC

NEWAMSTERDAM PHARMA COMPANY

RAPT THERAPEUTICS INC

AURA BIOSCIENCES INC

Medicxi Ventures Management (Jersey) Ltd - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
CENTESSA PHARMACEUTICALS PLC	19963157	499278557	SPONSORED ADS
PHATHOM PHARMACEUTICALS INC	7464572	123837249	COM
NEWAMSTERDAM PHARMA COMPANY	2869565	100664340	ORDINARY SHARES
RAPT THERAPEUTICS INC	2794000	94632780	COM
AURA BIOSCIENCES INC	3039892	16567411	COM